Aligos Therapeutics
ALGS
ALGS
39 hedge funds and large institutions have $30.1M invested in Aligos Therapeutics in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% more funds holding
Funds holding: 35 → 39 (+4)
0.02% less ownership
Funds ownership: 2.55% → 2.53% (-0.02%)
Holders
39
Holding in Top 10
2
Calls
$4.05M
Puts
–
Top Buyers
| 1 | +$4.54M | |
| 2 | +$4.05M | |
| 3 | +$1.91M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.62M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$861K |
Top Sellers
| 1 | -$914K | |
| 2 | -$756K | |
| 3 | -$268K | |
| 4 |
Millennium Management
New York
|
-$41.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.06K |